- Report
- August 2026
- 473 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 395 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 386 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 384 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 383 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 506 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- August 2026
- 363 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- January 2026
- 180 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- January 2026
- 180 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Drug Pipelines
- May 2026
- 80 Pages
Global
From €1790EUR$2,000USD£1,530GBP
- Report
- November 2025
- 200 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Report
- May 2026
- 100 Pages
Global
From €2415EUR$2,699USD£2,065GBP
- Report
- November 2025
- 200 Pages
Global
From €7113EUR$7,950USD£6,083GBP
- Report
- November 2025
- 200 Pages
Global
From €7113EUR$7,950USD£6,083GBP

Serotonin is a neurotransmitter found in the central nervous system (CNS) that plays a role in regulating mood, appetite, sleep, and other bodily functions. It is a key target for drugs used to treat depression, anxiety, and other mental health disorders. Serotonin-based drugs are typically selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). These drugs work by blocking the reuptake of serotonin, allowing it to remain active in the brain for longer periods of time.
The serotonin market is a subset of the larger CNS drug market, which is estimated to be worth billions of dollars. It is a highly competitive market, with many large pharmaceutical companies vying for market share. Companies in the serotonin market include Eli Lilly, Pfizer, GlaxoSmithKline, AstraZeneca, and Bristol-Myers Squibb. Show Less Read more